# Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors

> **NCT04651452** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Carnegie Mellon University** · enrollment: 250 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **BEHAVIORAL:** Value Affirmation
- **BEHAVIORAL:** Reflective Journaling

## Key facts

- **NCT ID:** NCT04651452
- **Lead sponsor:** Carnegie Mellon University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-02-01
- **Primary completion:** 2026-04-30
- **Final completion:** 2026-04-30
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2025-10-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04651452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04651452, "Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04651452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*